Potassium

Potassium

SCHEMBL8054963

NS(=O)(=O)c1cccc(Cl)c1.[K]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 11/20 0.67
CA1 P00915 10/20 0.67
CA9 Q16790 7/20 0.57
CA12 O43570 6/20 0.57
CA14 Q9ULX7 4/20 0.57
CA4 P22748 3/20 0.57
CA13 Q8N1Q1 3/20 0.52
CA7 P43166 3/20 0.52
CA5A P35218 3/20 0.52
CA3 P07451 2/20 0.52
CA6 P23280 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 1/20 0.50
PGR P06401 1/20 0.50
PLA2G7 Q13093 1/20 0.50
MAPT P10636 1/20 0.50
MAOB P27338 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL964478 0.98 CA2 (0.70) CA2CA1CA9CA12CA14
SCHEMBL8054962 0.96 CA2 (0.67) CA2CA1CA9CA12CA14
SCHEMBL2398133 0.81 CA2 (1.00) CA2CA1CA9CA12CA14
SCHEMBL31435391 0.79 AKR1B1 (0.56) MEN1KMT2AALDH1A1PGRMMP2
SCHEMBL2199161 0.79 AKR1B1 (0.56) MEN1KMT2AALDH1A1PGRMMP2
SCHEMBL29960292 0.77 ALDH1A1 (0.59) MEN1KMT2AALDH1A1PGRMMP2
SCHEMBL29422524 0.77 ALDH1A1 (0.54) MEN1KMT2AALDH1A1PGRMMP2
SCHEMBL294451 0.77 ALDH1A1 (0.59) MEN1KMT2AALDH1A1PGRMMP2
SCHEMBL294450 0.77 PGR (0.53) MEN1KMT2AALDH1A1PGRMAPT
SCHEMBL8477676 0.77 ALDH1A1 (0.59) MEN1KMT2AALDH1A1PGRMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1086578-C Sulfonamides and their use HOFFMANN LA ROCHE (CH) 2002-06-26 CN disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed
CN-1170574-A Sulfonamides and their use HOFFMANN LA ROCHE (CH) 1998-01-21 CN disclosed